NOVACLINETM Polyspecific Anti-Human Globulin is prepared by blending supernatants produced by individual murine hybridoma cell line(two Anti-IgG cell line 5H4 and 8D2-8, one Anti-C3d cell line 86 5A2, one Anti-C3d cell line 139 4B4).
共有 1 個藥物證書使用此成份
- 申請商
- 永弘科技有限公司
- 適應症
- 含量
- 發證日期
- 2005-11-27